Pfizer Venture Investments

New York
cb
Founded:2004
Firm Location:New York • Connecticut • New York, New York • New York City
Investor Firms That Co-Invest with Pfizer Venture Investments
SR OneWebb Investment NetworkRA CapitalAME Cloud VenturesHardware ClubXtripe AngelsRA Capital ManagementNovartis Venture FundMDC Ventures (formerly KBS Ventures)Angel investorThe Column GroupAtlas VentureWellington PartnersThird Rock VenturesSamsara BioCapitalNew Enterprise Associates (NEA)Mott Family CapitalAvoro VenturesRedpoint VenturesKurma PartnersForbionOmega FundsAndera PartnersEarlybird Venture CapitalMPM CapitalPureos BioventuresBessemer Venture PartnersPolaris PartnersOrbiMedZintinusEQT Life SciencesInnovation WorksBling CapitalSofinnova PartnersM12 - Microsoft's Venture FundRiverfront Ventures
Pfizer Venture Investments Team
Photo of Rana Al-Hallaq, Partner at Pfizer Venture Investments
Rana Al-Hallaq
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Rana
Photo of Michael Baran, Partner at Pfizer Venture Investments
Michael Baran
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Michael
Photo of Barbara Dalton, Vice President at Pfizer Venture Investments
Barbara Dalton
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York (NY)
to see your intro paths to Barbara
Photo of Christopher O'Donnell, Partner at Pfizer Venture Investments
Christopher O'Donnell
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in Connecticut
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Pre-seed)
to see your intro paths to Christopher
Photo of Denis Patrick, Pfizer Venture Investments
Denis Patrick
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Denis
Photo of Nikola Trbovic, Partner at Pfizer Venture Investments
Nikola Trbovic
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Nikola